Published Oct 22, 2026, 8:50 PM ET · Updated 22 days ago · 1 source
Food Allergy Biotech Firm Lycia Raises $317.5 Million in US IPO
bloomberg
·
Original Report
Lycia Therapeutics Inc., a biotechnology firm focused on treatments for allergies and autoimmune diseases, raised $317.5 million in an upsized US initial public offering that priced at the top of its marketed range.